• CMS Holds External Stakeholders Meeting Regarding the Development of National Average Drug Acquisition Cost
  • August 9, 2011 | Authors: Elizabeth F. Gluck; Laura E. Loeb; Patrick Morrisey; Josh T. O'Harra; John D. Shakow
  • Law Firm: King & Spalding LLP - Washington Office
  • On Thursday, August 4, 2011, the Centers for Medicare and Medicaid Services (CMS) held a Stakeholders Meeting on the development of its new pricing metric, the “national average drug acquisition cost” or “NADAC.”